century_tx

@century_tx

Harnessing the power of stem cells to develop curative cell therapy products for cancer

Vrijeme pridruživanja: prosinac 2018.

Tweetovi

Blokirali ste korisnika/cu @century_tx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @century_tx

  1. prije 41 minutu

    Century Therapeutics is honored to join and MOBiLion Systems as the three Healthcare Startup finalists for 's 2020 Enterprise Awards which celebrate innovative life sciences and technology leaders in .

    Poništi
  2. 30. sij

    Century is honored to be named one of four finalists for the 2019 Emerging Company of the Year Award by . Learn about how we’re democratizing cancer care.

    Poništi
  3. 28. sij

    Century is happy to welcome Joe Jimenez to its Board of Directors and Greg Russotti as its CTO.

    Poništi
  4. 12. sij

    Century Therapeutics CEO Lalo Flores will speak on a panel at the Global Forum 2020 focused on Advancing Breakthroughs for Patients Tues at 4:10.

    Poništi
  5. 16. lis 2019.

    Great news for healthcare and business in , especially . Thanks to 's for including Century.

    Poništi
  6. 30. ruj 2019.

    Century's Carl Burke contributed to a new paper on risks to avoid on the path to for cell and gene therapy products.

    Poništi
  7. 24. ruj 2019.

    Our CEO Lalo Flores was honored to join Century's partner Fujifilm Friday to celebrate the opening of their 32,000-sq.ft. GMP cell manufacturing facility in Madison.

    Poništi
  8. 6. ruj 2019.
    Poništi
  9. proslijedio/la je Tweet
    9. kol 2019.

    .'s Chief Strategy Officer Janelle Anderson in conversation with on The Long Run

    Poništi
  10. 8. kol 2019.

    Our Chief Strategy Officer Janelle Anderson traced the steps of her path to biotechnology in the latest episode of ’s The Long Run podcast

    Poništi
  11. proslijedio/la je Tweet
    12. srp 2019.

    Afternoon innovation panel with from Liz Schwarzbach from and Lisa Ricciardi moderated by

    Poništi
  12. proslijedio/la je Tweet
    29. srp 2019.

    29July: Which private , pharma, and diagnostic/therapeutic technology companies raised the most in financings so far this year? My latest for --

    Poništi
  13. proslijedio/la je Tweet
    5. srp 2019.
    Poništi
  14. proslijedio/la je Tweet
    8. srp 2019.

    ICYMI: off-the-shelf iPSC company Century Therapeutics debuted last week with $250M from and Versant. Read why the partners think iPSCs can tackle the stumbling blocks of CAR therapies:

    Poništi
  15. proslijedio/la je Tweet
    1. srp 2019.

    ., a Philadelphia-based biotech startup, received $250 million in venture financing to continue developing cellular therapy treatments for cancer.

    Poništi
  16. proslijedio/la je Tweet
    3. srp 2019.
    Poništi
  17. proslijedio/la je Tweet
    3. srp 2019.

    Startup Century Therapeutics seeks cancer cures through new type of cellular therapy

    Poništi
  18. proslijedio/la je Tweet
    3. srp 2019.

    Century Therapeutics wants to develop off-the-shelf cancer cell therapies. Now it has $250 million in funding behind it.

    Poništi
  19. proslijedio/la je Tweet
    1. srp 2019.

    We’re partnering with to develop curative therapies for cancer using . Learn more here:

    Poništi
  20. proslijedio/la je Tweet
    1. srp 2019.

    Cancer is one of today’s biggest health concerns and available therapies are limited. Together with Versant Ventures and , we are investing USD 250 million to support the development of new treatments. Read more:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·